Images
The newspaper “El País” interviews Manuel Serrano, group leader of the Cellular Plasticity and Disease Lab, on the occasion of his recent incorporation at IRB Barcelona thanks to the ICREA programme and the Obra Social "la Caixa".
In the interview, Manuel Serrano talks about anti-ageing treatments, with a special focus on his studies on how damaged tissue is repaired and the search for therapies based on regenerative medicine for the treatment of diabetes and pulmonary fibrosis. He also talks about his first spin-off, Senolytic Therapeutics, aimed at bringing a drug to clinical trials to remove cells that build up in damaged tissue.
Read the full interview in “El País” newspaper (in Spanish)
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
